SOLANGE SIERRA: Open Payments
NPI 1427525575 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,535 in 25 payments from 9 companies in 2025. Trend: 2023 $365 · 2024 $968 · 2025 $8,535
Speaker / faculty: $3,881Travel & lodging: $2,139Consulting: $1,470Food & beverage: $1,045
| Company | Payments | Amount |
|---|---|---|
| Deciphera Pharmaceuticals Inc. | 8 | $5,014 |
| Ares Trading SA | 2 | $1,135 |
| EMD Serono, Inc. | 1 | $1,040 |
| Aadi Bioscience, Inc. | 4 | $517 |
| Daiichi Sankyo Inc. | 2 | $430 |
| SpringWorks Therapeutics, Inc. | 5 | $225 |
| AstraZeneca Pharmaceuticals LP | 1 | $124 |
| Caris MPI, Inc. | 1 | $31 |
| Gilead Sciences, Inc. | 1 | $19 |
Products named: ROMVIMZA, Fyarro, Turalio, OGSIVEO, GOMEKLI, MI CANCER SEEK, Trodelvy.
Industry payments across FL — which companies pay providers there.
